Aims/introduction:
To systematically review the risk factors for new-onset diabetes mellitus after kidney transplantation, and to provide a theoretical basis for the prevention and management of new-onset diabetes mellitus after kidney transplantation.
Materials And Methods:
We searched PubMed, Web of Science, Embase, the Cochrane Library databases and other databases for case-control studies related to risk factors for new-onset diabetes mellitus after kidney transplantation published between January 2005 and July 2019. A meta-analysis of data on risk factors for new-onset diabetes mellitus after kidney transplantation from the included studies was carried out. A narrative review of risk factors for new-onset diabetes mellitus after kidney transplantation was also carried out.
Results:
A total of 24 case-control studies were included in the meta-analysis, with a total of 7,140 patients. There were 1,598 patients with new-onset diabetes mellitus after kidney transplantation, and 5,542 patients without new-onset diabetes mellitus after kidney transplantation. The meta-analysis results showed that age, polycystic kidney disease, family history of diabetes, body mass index, acute rejection, tacrolimus use, hepatitis B virus infection, hepatitis C virus infection and hypertension were associated with new-onset diabetes mellitus after kidney transplantation, whereas sex, sirolimus use, cyclosporin A use, steroid use and cytomegalovirus infection were not associated with new-onset diabetes mellitus after kidney transplantation.
Conclusions:
Older age, body mass index, family history of diabetes, tacrolimus use, history of hypertension, polycystic kidney disease, acute rejection, hepatitis B virus infection and hepatitis C virus infection are risk factors for new-onset diabetes mellitus after kidney transplantation. Therefore, the clinical implications of these factors warrant attention.
Citing Articles
HbA1c changes in the first year post-kidney transplant and associated risk factors in a Saudi cohort.
Arabi Z, Alghamdi H, Arabi T, Shafqat A, Elwy B, Sabbah B
Ther Adv Endocrinol Metab. 2024; 15:20420188241301940.
PMID: 39619270
PMC: 11607771.
DOI: 10.1177/20420188241301940.
Elevated Plasma High Sensitive C-Reactive Protein and Triglyceride/High-Density Lipoprotein Cholesterol Ratio are Risks Factors of Diabetes Progression in Prediabetes Patients After Kidney Transplant: A 3-Year Single-Center Study in Vietnam.
Le Ha K, Nguyen Van D, Do Manh H, Thi D, Trung K, Le Viet T
Int J Gen Med. 2024; 17:5095-5103.
PMID: 39526064
PMC: 11550698.
DOI: 10.2147/IJGM.S490561.
Impact of Immunosenescence in Older Kidney Transplant Recipients: Associated Clinical Outcomes and Possible Risk Stratification for Immunosuppression Reduction.
Jallah B, Kuypers D
Drugs Aging. 2024; 41(3):219-238.
PMID: 38386164
DOI: 10.1007/s40266-024-01100-5.
Post-transplant diabetes mellitus: risk factors and outcomes in a 5-year follow-up.
Rossi M, Mazzali M, de Sousa M
Front Clin Diabetes Healthc. 2024; 5:1336896.
PMID: 38352660
PMC: 10863447.
DOI: 10.3389/fcdhc.2024.1336896.
Postoperative fasting plasma glucose and family history diabetes mellitus can predict post-transplantation diabetes mellitus in kidney transplant recipients.
Wang L, Huang J, Li Y, Shi K, Gao S, Zhao W
Endocrine. 2023; 81(1):58-66.
PMID: 37148416
DOI: 10.1007/s12020-023-03374-y.
Progress of new-onset diabetes after liver and kidney transplantation.
Zhang Z, Sun J, Guo M, Yuan X
Front Endocrinol (Lausanne). 2023; 14:1091843.
PMID: 36843576
PMC: 9944581.
DOI: 10.3389/fendo.2023.1091843.
Post-kidney transplant body mass index trajectories are associated with graft loss and mortality.
Liu Y, Bendersky V, Chen X, Ghildayal N, Harhay M, Segev D
Clin Transplant. 2023; 37(5):e14947.
PMID: 36811329
PMC: 10175140.
DOI: 10.1111/ctr.14947.
New Onset of Diabetes Mellitus and Associated Factors among COVID-19 Patients in COVID-19 Care Centers, Addis Ababa, Ethiopia 2022.
Sane A, Mekonnen M, Tsegaw M, Zewde W, Mesfin E, Beyene H
J Diabetes Res. 2022; 2022:9652940.
PMID: 36420090
PMC: 9678479.
DOI: 10.1155/2022/9652940.
LASSO-derived nomogram predicting new-onset diabetes mellitus in patients with kidney disease receiving immunosuppressive drugs.
Shao L, Luo C, Yuan C, Ye X, Zeng Y, Ren Y
J Clin Pharm Ther. 2022; 47(10):1627-1635.
PMID: 35791031
PMC: 9796007.
DOI: 10.1111/jcpt.13713.
Cytomegalovirus infection after renal transplantation.
Al Atbee M, Tuama H
J Med Life. 2022; 15(1):71-77.
PMID: 35186139
PMC: 8852648.
DOI: 10.25122/jml-2021-0209.
Impact of diabetes mellitus developing after kidney transplantation on patient mortality and graft survival: a meta-analysis of adjusted data.
Lin H, Yan J, Yuan L, Qi B, Zhang Z, Zhang W
Diabetol Metab Syndr. 2021; 13(1):126.
PMID: 34717725
PMC: 8557540.
DOI: 10.1186/s13098-021-00742-4.
Obesity and bariatric surgery in kidney transplantation: A clinical review.
Veroux M, Mattone E, Cavallo M, Gioco R, Corona D, Volpicelli A
World J Diabetes. 2021; 12(9):1563-1575.
PMID: 34630908
PMC: 8472502.
DOI: 10.4239/wjd.v12.i9.1563.
Association of serum adiponectin and leptin levels with renal function in kidney transplant recipients with or without new-onset diabetes after transplantation.
Vu T, Van M, Dang Thanh C, Nguyen Minh T, Trung K, Nguyen Duy T
J Clin Lab Anal. 2021; :e24000.
PMID: 34519108
PMC: 8551688.
DOI: 10.1002/jcla.24000.
Obesity and Post-Transplant Diabetes Mellitus in Kidney Transplantation.
Martin-Moreno P, Shin H, Chandraker A
J Clin Med. 2021; 10(11).
PMID: 34198724
PMC: 8201168.
DOI: 10.3390/jcm10112497.
Risk factors for new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis.
Xia M, Yang H, Tong X, Xie H, Cui F, Shuang W
J Diabetes Investig. 2020; 12(1):109-122.
PMID: 32506801
PMC: 7779280.
DOI: 10.1111/jdi.13317.